Form 4 for VKTX Viking Therapeutics, Inc.
Accepted 2022-02-11 00:00:00 ET · period of report 2022-01-15 · accession 0001209191-22-008999 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-11 | 2022-01-15 | VKTX | Mancini Marianna | COO | F - Tax | $4.24 | -827 | 238.7K | -0.3% | -$3,506 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2022-01-15 | F | D | 827 | $4.24 | 238,695 | D | — | — |